A new study links serious renal side effects in men to antibiotics recognized as fluoroquinolones – more commonly known as Levaquin, Cipro and Avelox.
The Canadian Medical Association (CMA) published an article in its June 2013 medical journal that warns patients of “the use of fluoroquinolones may lead to acute kidney injury.”
The study compiled men ranging from 40 to 85 years of age who were enrolled in the United States IMS Life Link Health Plan ...
continue reading...
The U.S. Food and Drug Administration has issued a warning that the kidney drug tolvaptan, sold under the brand name “Samsca,” carries a risk of liver injuries, “potentially leading to liver transplant or death.”
